
### [MONDO:0016511](http://purl.obolibrary.org/obo/MONDO_0016511)
**Label:** infectious embryofetopathy

**Subclasses:** [MONDO:0017453](http://purl.obolibrary.org/obo/MONDO_0017453) (fetal parvovirus syndrome), [MONDO:0017375](http://purl.obolibrary.org/obo/MONDO_0017375) (congenital enterovirus infection), [MONDO:0017361](http://purl.obolibrary.org/obo/MONDO_0017361) (congenital rubella syndrome), [MONDO:0017372](http://purl.obolibrary.org/obo/MONDO_0017372) (congenital varicella syndrome), [MONDO:0017409](http://purl.obolibrary.org/obo/MONDO_0017409) (fetal cytomegalovirus syndrome), [MONDO:0005715](http://purl.obolibrary.org/obo/MONDO_0005715) (congenital toxoplasmosis), [MONDO:0019094](http://purl.obolibrary.org/obo/MONDO_0019094) (congenital Epstein-Barr virus infection), [MONDO:0017381](http://purl.obolibrary.org/obo/MONDO_0017381) (congenital herpes simplex virus infection), 

**Corr. equiv. classes:** [Orphanet:294](http://www.orpha.net/ORDO/Orphanet_294), [Orphanet:293](http://www.orpha.net/ORDO/Orphanet_293), [Orphanet:295](http://www.orpha.net/ORDO/Orphanet_295), [Orphanet:290](http://www.orpha.net/ORDO/Orphanet_290), [Orphanet:70596](http://www.orpha.net/ORDO/Orphanet_70596), [Orphanet:858](http://www.orpha.net/ORDO/Orphanet_858), [Orphanet:292](http://www.orpha.net/ORDO/Orphanet_292), [Orphanet:291](http://www.orpha.net/ORDO/Orphanet_291), 

**Class expressions from DL-Learner:**

- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001627](http://purl.obolibrary.org/obo/HP_0001627) (Abnormal heart morphology) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001627](http://purl.obolibrary.org/obo/HP_0001627) (Abnormal heart morphology) and [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001627](http://purl.obolibrary.org/obo/HP_0001627) (Abnormal heart morphology) and [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001627](http://purl.obolibrary.org/obo/HP_0001627) (Abnormal heart morphology) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) 62.50%
- [HP:0001511](http://purl.obolibrary.org/obo/HP_0001511) (Intrauterine growth retardation) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0001627](http://purl.obolibrary.org/obo/HP_0001627) (Abnormal heart morphology) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 62.50%


